UCLA researchers may have identified a type of dysfunctional immune cell that accumulates in aging livers and drives fatty liver disease. Studies in mice suggest these cells can be eliminated to reverse organ damage. The research points to a possible new treatment strategy for a condition that affects roughly 30% of the global population, with particularly high rates in Latino communities — where prevalence may reach nearly 50%.
The conventional approach to fatty liver disease centers on diet and lifestyle changes. Lose weight, cut the cholesterol, exercise more. But recent research suggests something more stubborn may be happening at the cellular level, something that persists even when the damage seems like it should stop.
Researchers have focused on macrophages, a type of immune cell responsible for cleaning up damaged tissue. As mice aged, or were fed high-fat, high-cholesterol diets, a growing share of these macrophages became senescent: alive but no longer functioning, stuck in place and pumping out inflammatory signals. Scientists call them “zombie” cells. In aging mice, roughly 15–20% of liver macrophages showed senescent markers, compared to fewer than 5% in young mice — a three- to fourfold increase that correlated with worsening liver inflammation and fat accumulation.
Research has explored molecular signatures that may distinguish these zombie macrophages from healthy ones. High LDL cholesterol exposure appears to trigger the transformation, causing healthy macrophages to stop dividing and start producing inflammatory proteins. That link between cholesterol and cellular aging is worth paying attention to: it suggests that what we eat doesn’t just affect fat deposits in the liver but may accelerate the aging of the immune cells within it.
When scientists used senolytic drugs to clear senescent cells from mice fed a high-fat, high-cholesterol diet, the results were striking. Liver size decreased by approximately 30–40%, and body weight dropped meaningfully — all without any changes to the animals’ diet. The liver damage appeared to reverse, with reduced fat deposits and lower levels of inflammatory markers.
